#South Korea #Seoul #Clinical Trials #HiRO #CHA Medical Center

HiRO and CHA University Bundang Medical Center: A New Era in Clinical Research

On December 15, 2024, the Harvest Integrated Research Organization (HiRO), a global boutique clinical research organization (CRO), announced an exciting collaboration with the prestigious CHA University Bundang Medical Center (CBMC) in South Korea. This partnership, marked by the signing of a Memorandum of Understanding (MOU), is set to enhance clinical trial processes and contribute significantly to healthcare research innovations both regionally and globally.

Strengthening Clinical Trial Processes

HiRO and CBMC aim to collaborate closely in delivering comprehensive solutions for global biotech and pharmaceutical companies, focusing on all phases of clinical trials, from Phase I to Phase IV. The partnership will leverage the extensive expertise of both organizations, streamlining clinical trial procedures to ensure efficient and effective research outcomes.

CHA University Bundang Medical Center, as part of the CHA Medical Group—one of South Korea's largest and most renowned biomedical groups— is well-known for its cutting-edge medical services and strong research capabilities. The collaboration will emphasize delivering essential insights and support for clinical trials at CBMC, including conducting feasibility assessments, selecting principal investigators, and facilitating effective patient recruitment processes.

In exchange, HiRO will promote the clinical research prowess of South Korea and CBMC on international platforms, showcasing the center’s remarkable facilities, skilled professionals, and dedication to research excellence.

Voices of Leadership

Dr. Young-Sang Kim, Director of the CHA Global Clinical Trials Center, expressed optimism about the partnership, highlighting its potential to elevate clinical research standards and medical excellence. He stated, "Through our partnership with HiRO, we are poised to elevate our clinical research expertise and medical excellence. Drawing on HiRO's presence across the US, Europe, and the Asia-Pacific region, we are reinforcing our commitment to providing more effective and pioneering treatments on a global scale."

Similarly, Dr. Karen Chu, the Founder and CEO of HiRO, shared her enthusiasm about the collaboration. She remarked, "South Korea is a prime destination for clinical trials, boasting a robust healthcare infrastructure and a favorable research environment. Our collaboration with CBMC represents a strategic alignment of our missions to provide top-notch services to our global clients and drive their innovation forward."

Future Collaborations and Innovations

Both HiRO and CBMC share a commitment to pursuing innovative opportunities as partners. The establishment of the MOU signifies the beginning of a promising collaboration that aims to shape the future of clinical research not only in South Korea but also across the globe. This partnership denotes an important milestone in the integration of clinical research efforts, pushing the frontier of medical advancements and facilitating access to groundbreaking treatments for patients in need.

Overview of HiRO and CBMC

HiRO is an emerging leader in the clinical research field, delivering a wide range of cross-border solutions including early pre-clinical strategic planning, clinical trial design, regulatory affairs, and pharmacovigilance. The organization aspires to be a market-leading integrated CRO, facilitating the journey of new medical products from laboratories to markets globally. More information about HiRO can be found at www.harvestiro.com.

CHA University Bundang Medical Center, established in 1995, stands as a pioneering medical institution recognized for its advanced healthcare services and expertise in specialized areas like fertility treatment and oncology. This leading center is equipped with state-of-the-art facilities and continues to make significant contributions to clinical care and research. For further details, visit bundang.chamc.co.kr.

In conclusion, the partnership between HiRO and CHA University Bundang Medical Center is set to generate impactful outcomes for clinical research, ultimately enriching the healthcare landscape in South Korea and beyond.